99 related articles for article (PubMed ID: 27631803)
21. An extended consensus motif enhances the specificity of substrate modification by SUMO.
Yang SH; Galanis A; Witty J; Sharrocks AD
EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
[TBL] [Abstract][Full Text] [Related]
22. Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process.
Wang YT; Chuang JY; Shen MR; Yang WB; Chang WC; Hung JJ
J Mol Biol; 2008 Jul; 380(5):869-85. PubMed ID: 18572193
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
Watanabe M; Itoh K
Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
[TBL] [Abstract][Full Text] [Related]
24. Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors.
Khaiboullina SF; Morzunov SP; Boichuk SV; Palotás A; St Jeor S; Lombardi VC; Rizvanov AA
Virology; 2013 Sep; 443(2):338-48. PubMed ID: 23830076
[TBL] [Abstract][Full Text] [Related]
25. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
[TBL] [Abstract][Full Text] [Related]
26. Chip-based analysis of SUMO (small ubiquitin-like modifier) conjugation to a target protein.
Oh YH; Hong MY; Jin Z; Lee T; Han MK; Park S; Kim HS
Biosens Bioelectron; 2007 Feb; 22(7):1260-7. PubMed ID: 16820290
[TBL] [Abstract][Full Text] [Related]
27. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
Engelhardt OG; Ullrich E; Kochs G; Haller O
Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
[TBL] [Abstract][Full Text] [Related]
28. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
[TBL] [Abstract][Full Text] [Related]
29. Ribosomal protein S3 is stabilized by sumoylation.
Jang CY; Shin HS; Kim HD; Kim JW; Choi SY; Kim J
Biochem Biophys Res Commun; 2011 Oct; 414(3):523-7. PubMed ID: 21968017
[TBL] [Abstract][Full Text] [Related]
30. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells.
Jo S; Lee YL; Kim S; Lee H; Chung H
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1499-509. PubMed ID: 27030546
[TBL] [Abstract][Full Text] [Related]
31. Purification of SUMO-1 modified IκBα and complex formation with NF-κB.
Lens Z; Dewitte F; Van Lint C; de Launoit Y; Villeret V; Verger A
Protein Expr Purif; 2011 Dec; 80(2):211-6. PubMed ID: 21708266
[TBL] [Abstract][Full Text] [Related]
32. A simple in situ cell-based sumoylation assay with potential application to drug screening.
Muramatsu M; Uwada J; Matsumoto N; Saitoh H
Biosci Biotechnol Biochem; 2010; 74(7):1473-5. PubMed ID: 20622442
[TBL] [Abstract][Full Text] [Related]
33. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
34. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the C-terminal diglycine motif of SUMO-1/3.
Yamada K; Muramatsu M; Saito D; Sato-Oka M; Saito M; Moriyama T; Saitoh H
Biosci Biotechnol Biochem; 2012; 76(5):1035-7. PubMed ID: 22738983
[TBL] [Abstract][Full Text] [Related]
36. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
Sahin U; de Thé H; Lallemand-Breitenbach V
Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
[TBL] [Abstract][Full Text] [Related]
37. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
[TBL] [Abstract][Full Text] [Related]
38. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
39. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
40. Using Biotinylated SUMO-Traps to Analyze SUMOylated Proteins.
Lang V; Da Silva-Ferrada E; Barrio R; Sutherland JD; Rodriguez MS
Methods Mol Biol; 2016; 1475():109-21. PubMed ID: 27631801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
